The consequences of US tariffs on Mexican imports of medtech would be almost imponderable, given Mexico’s world-leading role as the medtech nearshoring gateway to the US. Some 90% of its global exports – worth US$11.3bn in 2021 – go to the US. That figure is twice the size of Mexico’s domestic market.
Mexico’s Medtech Ecosystem Weighs US Tariff Moves But Braces For Turmoil
‘Great Uncertainty’ For Manufacturing, Bilateral Trade And ‘Unprecedented Economic Implications’
The US administration added another layer of confusion after its overnight pronouncements on Mexican tariffs. For medtech, the uncertainty remains, and while the potential impact on the industry might still seem to be a simple question of bilateral trade math, which in itself is huge, the ramifications go even deeper – and wider, writes Bernard Murphy.
